
IgA Nephropathy Drugs Market to Grow at 18.1% CAGR Driven by Biologic Innovations and FDA Approvals| DataM Intelligence
The IgA Nephropathy drugs market is set for 18.1% CAGR growth, led by biologics, FDA approvals, and major pharma R&D efforts worldwide. NEW YORK, NY, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Market Overview: The IgA Nephropathy …